Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Akebia Therapeutics, Inc. - Common Stock (NQ:AKBA)

2.040 +0.030 (+1.49%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,475,770
Open 2.020
Bid (Size) 2.040 (200)
Ask (Size) 2.060 (100)
Prev. Close 2.010
Today's Range 1.960 - 2.070
52wk Range 1.520 - 4.079
Shares Outstanding 174,537,458
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
An Overview of Akebia Therapeutics's Earnings
 
Via Benzinga
Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November
 
Via Benzinga

Performance

YTD
+7.4%
+7.4%
1 Month
-28.4%
-28.4%
3 Month
-40.4%
-40.4%
6 Month
-20.0%
-20.0%
1 Year
+9.4%
+9.4%

More News

Read More
FDA Pushback Prompts Akebia To Drop Broad Label Pursuit For Kidney Disease Drug
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Akebia Therapeutics Stock Slumps After FDA Meeting Ends Without Path Forward for Vafseo Label Expansion
Via Stocktwits
Earnings Scheduled For August 7, 2025
Via Benzinga
Earnings Preview For Akebia Therapeutics
Via Benzinga
Earnings Scheduled For May 8, 2025
Via Benzinga
Insights Ahead: Akebia Therapeutics's Quarterly Earnings
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Mondelez International, Stride, Varonis Systems And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Why Teradyne Shares Are Trading Higher By More Than 20%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Wondering what's happening in today's after-hours session?
Via Chartmill
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Akebia (AKBA) Q2 Revenue Jumps 43%
Via The Motley Fool
9 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Here are the top movers in Thursday's session.
Via Chartmill
Top movers in Thursday's session
Via Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Which stocks are gapping on Thursday?
Via Chartmill
Crude Oil Gains Over 1%; US Weekly Jobless Claims Increase
Via Benzinga
Stay updated with the stocks that are on the move in today's pre-market session.
Via Chartmill
JOYY, Akebia Therapeutics, Microchip Technology And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga

Frequently Asked Questions

Is Akebia Therapeutics, Inc. - Common Stock publicly traded?
Yes, Akebia Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Akebia Therapeutics, Inc. - Common Stock trade on?
Akebia Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Akebia Therapeutics, Inc. - Common Stock?
The ticker symbol for Akebia Therapeutics, Inc. - Common Stock is AKBA on the Nasdaq Stock Market
What is the current price of Akebia Therapeutics, Inc. - Common Stock?
The current price of Akebia Therapeutics, Inc. - Common Stock is 2.040
When was Akebia Therapeutics, Inc. - Common Stock last traded?
The last trade of Akebia Therapeutics, Inc. - Common Stock was at 11/07/25 04:00 PM ET
What is the market capitalization of Akebia Therapeutics, Inc. - Common Stock?
The market capitalization of Akebia Therapeutics, Inc. - Common Stock is 356.06M
How many shares of Akebia Therapeutics, Inc. - Common Stock are outstanding?
Akebia Therapeutics, Inc. - Common Stock has 356M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.